Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 6

The distribution of Toxoplasma gondii and Toxocara antibodies in patients with schizophrenia disorder based on their residential area.

	Patients' group
	𝑁 (%)		Sig	OR	CI
	Urban	Rural
Toxoplasma  gondii	16/76 (21.05%)	4/24 (16.66%)	0.7	1.36	0.39–4.7
Toxocara	6/76 (7.89%)	3/24 (12.5%)	0.3	1.7	0.37–7.6